Click Sign-Up Today to register an account to access your prescriptions.
Please note: Your previous login credentials will not work with this new service.
Download our NEW Mobile App! See details below!
Experimental Drug Shows Promise in Slowing Disability from Multiple Sclerosis
Results of a phase 3 clinical trial show an experimental drug called tolebrutinib can delay disability in patients with non-relapsing secondary progressive multiple sclerosis.
Health News is provided as a service to Tinsley Bible Drug Co. site users by HealthDay. Tinsley Bible Drug Co. nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.